The STARD (StAR-related lipid transfer domain containing) family of proteins plays a critical role in the intracellular transport and metabolism of lipids, a process essential for various cellular functions. These proteins are characterized by their ability to bind and transfer cholesterol and other lipids across cellular membranes, facilitating the movement of these molecules within cells and to specific organelles. One of the most well-known members, StAR (Steroidogenic Acute Regulatory protein), a prototype of this family, is crucial in steroidogenesis, where it transports cholesterol to the mitochondria, the site of steroid hormone synthesis. Other STARD proteins are involved in different aspects of lipid metabolism, including the transport of lipids to lipid droplets, membranes, and other locations within the cell. The proper functioning of STARD proteins is essential for maintaining cellular lipid homeostasis, and dysregulation in their activity can lead to metabolic disorders and diseases related to lipid metabolism.
Inhibitors targeting these proteins are developed to modulate these lipid transport processes by binding to specific sites on the STARD proteins, thus their interaction with lipids or disrupting their normal conformational dynamics. Such inhibition is crucial for understanding the mechanistic aspects of lipid transport within cells and the role of STARD proteins in these processes. Developing inhibitors for STARD proteins involves a thorough understanding of the protein structure, particularly the lipid-binding domains and regions responsible for membrane interactions.
VOIR ÉGALEMENT...
Nom du produit | CAS # | Ref. Catalogue | Quantité | Prix HT | CITATIONS | Classement |
---|---|---|---|---|---|---|
Lipase Inhibitor, THL | 96829-58-2 | sc-203108 | 50 mg | $51.00 | 7 | |
L'orlistat inhibe les lipases gastriques et pancréatiques, ce qui pourrait indirectement affecter les transporteurs de lipides ou les protéines du métabolisme des lipides. | ||||||
Nicotinic Acid | 59-67-6 | sc-205768 sc-205768A | 250 g 500 g | $61.00 $122.00 | 1 | |
La niacine (vitamine B3) affecte le métabolisme des lipides, influençant potentiellement les transporteurs de lipides et les protéines associées. | ||||||
SMIFH2 | 340316-62-3 | sc-507273 | 5 mg | $140.00 | ||
SMIFH2 est une petite molécule inhibitrice qui perturbe la liaison de STARD13 au cytosquelette d'actine, ce qui affecte la migration cellulaire et pourrait avoir des implications dans les métastases du cancer. | ||||||
Probucol | 23288-49-5 | sc-203666 sc-203666A | 100 mg 1 g | $77.00 $163.00 | 5 | |
Un antioxydant qui affecte également le transport du cholestérol et pourrait affecter indirectement les protéines transportant les lipides. | ||||||
Ezetimibe | 163222-33-1 | sc-205690 sc-205690A | 25 mg 100 mg | $94.00 $236.00 | 12 | |
Cible spécifiquement l'absorption intestinale du cholestérol, ce qui pourrait influencer les transporteurs de lipides dans l'intestin. | ||||||
Gemfibrozil | 25812-30-0 | sc-204764 sc-204764A | 5 g 25 g | $65.00 $262.00 | 2 | |
Médicament à base de fibrate qui abaisse les taux de lipides et peut affecter les transporteurs de lipides ou les protéines associées. | ||||||
Atorvastatin | 134523-00-5 | sc-337542A sc-337542 | 50 mg 100 mg | $252.00 $495.00 | 9 | |
Une statine qui inhibe la HMG-CoA réductase, influençant potentiellement les transporteurs de lipides en aval. | ||||||
Clofibrate | 637-07-0 | sc-200721 | 1 g | $32.00 | ||
Un autre médicament à base de fibrate qui affecte le métabolisme des lipides et qui pourrait influencer les transporteurs de lipides. | ||||||
CHOLESTYRAMINE RESIN | 11041-12-6 | sc-507509 | 5 g | $210.00 | ||
Séquestrant des acides biliaires qui affecte le métabolisme des lipides et pourrait indirectement influencer les transporteurs de lipides. |